The impact of regulatory restrictions on pregabalin use in Saudi Arabia: An interrupted time series analysis
Sign Up to like & getrecommendations! Published in 2022 at "Pharmacoepidemiology and Drug Safety"
DOI: 10.1002/pds.5408
Abstract: The Saudi Food and Drug Authority (SFDA) added pregabalin to the list of controlled substances in December 2017 to minimize the risk of its possible abuse and misuse. This study was aimed at assessing the… read more here.
Keywords: restrictions pregabalin; saudi arabia; regulatory restrictions; impact regulatory ... See more keywords